Rapid Micro Biosystems, Inc.

NASDAQ:RPID

1.24 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 7.6046.6185.6116.3376.1455.0025.0354.3744.7393.864.165.2086.8996.134.9955.2385.2472.5932.999
Cost of Revenue 1.4636.8077.1346.5097.7766.8946.8256.9757.5335.0816.0847.7948.217.9087.0618.3946.6124.1824.96
Gross Profit 6.141-0.189-1.523-0.172-1.631-1.892-1.79-2.601-2.794-1.221-1.924-2.586-1.311-1.778-2.066-3.156-1.365-1.589-1.961
Gross Profit Ratio 0.808-0.029-0.271-0.027-0.265-0.378-0.356-0.595-0.59-0.316-0.463-0.497-0.19-0.29-0.414-0.603-0.26-0.613-0.654
Reseach & Development Expenses 3.6093.7443.8423.3183.1163.2333.1533.4032.9732.9653.5252.8552.4412.3372.1471.6252.2241.2441.438
General & Administrative Expenses 5.6765.8185.6275.5376.2046.7286.4677.1327.1896.4046.0945.765.3083.6253.2033.1212.5411.9432.371
Selling & Marketing Expenses 3.3763.6273.2813.1613.4983.2013.4624.1243.933.4843.4563.3553.0633.1222.2751.8131.4471.2361.466
SG&A 9.0529.4458.9088.6989.7029.9299.92911.25611.1199.8889.559.1158.3716.7475.4784.9343.9883.1793.837
Other Expenses 5.519-0.023-0.029-0.017-0.026-0.029-0.011-0.011-0.0210.3810.1030.004-0.8090.008-0.011-0.0020.018-0.0010.007
Operating Expenses 18.1813.18912.7512.01612.81813.16213.08214.65914.09212.85313.07511.9710.8129.0847.6256.5596.2124.4235.275
Operating Income -12.039-13.378-14.273-12.188-14.449-15.054-14.872-17.26-16.886-14.074-14.999-14.556-12.123-10.862-9.691-9.715-7.577-6.012-7.236
Operating Income Ratio -1.583-2.021-2.544-1.923-2.351-3.01-2.954-3.946-3.563-3.646-3.606-2.795-1.757-1.772-1.94-1.855-1.444-2.319-2.413
Total Other Income Expenses Net 0.7290.8150.9541.024-0.026-0.0290.9920.820.5540.3710.0920.004-12.069-0.027-11.459-0.620.018-2.3670.012
Income Before Tax -11.31-12.563-13.319-11.164-13.382-14.01-13.88-16.44-16.332-13.703-14.907-14.571-24.967-11.813-22.082-11.319-8.445-9.193-7.987
Income Before Tax Ratio -1.487-1.898-2.374-1.762-2.178-2.801-2.757-3.759-3.446-3.55-3.583-2.798-3.619-1.927-4.421-2.161-1.609-3.545-2.663
Income Tax Expense 0.0130.0150.0030.0080.010.0060.0070.0070.007-0.6130.0230.0340.020.0180.0190.020.020.0740.02
Net Income -11.323-12.578-13.322-11.172-13.392-14.016-13.887-16.447-16.339-13.09-14.93-14.605-24.987-11.831-22.101-11.339-8.465-9.267-8.007
Net Income Ratio -1.489-1.901-2.374-1.763-2.179-2.802-2.758-3.76-3.448-3.391-3.589-2.804-3.622-1.93-4.425-2.165-1.613-3.574-2.67
EPS -0.26-0.29-0.31-0.26-0.31-0.33-0.32-0.39-0.38-0.31-0.35-0.35-0.71-0.31-0.7-0.36-0.27-0.29-0.25
EPS Diluted -0.26-0.29-0.31-0.26-0.31-0.33-0.32-0.39-0.38-0.31-0.35-0.35-0.71-0.31-0.7-0.36-0.27-0.29-0.25
EBITDA -13.249-12.55-13.162-11.394-13.668-14.283-14.872-17.26-16.152-13.693-14.336-14.552-12.549-10.854-9.358-9.398-7.226-5.63-6.755
EBITDA Ratio -1.742-1.896-2.346-1.798-2.224-2.855-2.954-3.946-3.408-3.547-3.446-2.794-1.819-1.771-1.873-1.794-1.377-2.171-2.252